This consecutive case series provides clinical evidence of the safety, effectiveness, and clinical utility of a bioabsorbable steroid-eluting implant for use in CRS patients.
The implant was associated with favorable rates of sinus patency.
At 1 month, minimal degrees of inflammation and adhesions were observed, suggesting a positive clinical impact of local steroid delivery without evidence of ocular risk.
2011-10-24
Eng.
Advanced ENT and Allergy, Louisville, Kentucky 40207, USA. kforwith [at] commonwealthent.com
Laryngoscope. 2011 Nov;121(11):2473-80
© Galenicom 1999-2013